BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2857083)

  • 1. Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test.
    Waldmeier PC; Huber H; Heinrich M; Stoecklin K
    Biochem Pharmacol; 1985 Jan; 34(1):39-44. PubMed ID: 2857083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.
    Rivest R; Jolicoeur FB; Marsden CA
    Brain Res; 1991 Mar; 544(1):86-93. PubMed ID: 1677303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
    Brougham LR; Conway PG; Ellis DB
    Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitability of amfonelic acid-induced locomotor stimulation in mice as a model for the evaluation of classical and atypical antipsychotics.
    Menon MK; Haddox VG
    Neuropharmacology; 1984 May; 23(5):555-61. PubMed ID: 6146108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flumezapine and zotepine: 5-hydroxytryptamine antagonism not involved in the lack of synergism of these antipsychotic drugs with amfonelic acid in rats.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1985 Oct; 37(10):755-6. PubMed ID: 2867152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amfonelic acid on 5-HT metabolism in rat brain.
    Waldmeier PC; Buchle AM; Stoecklin K; Fehr B; Feldtrauer JJ
    J Neural Transm; 1983; 57(3):149-65. PubMed ID: 6196442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amfonelic acid with antipsychotic drugs on dopaminergic neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Synapse; 1992 Dec; 12(4):304-11. PubMed ID: 1361248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drug.
    Westerink BH; Korf J
    Brain Res; 1976 Aug; 113(2):429-34. PubMed ID: 953748
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of amfonelic acid and some other central stimulants on mouse striatal tyramine, dopamine and homovanillic acid.
    Juorio AV
    Br J Pharmacol; 1982 Nov; 77(3):511-5. PubMed ID: 7139200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
    Gaĭnetdinov RR; Budygin EA; Kovalev GI; Kudrin VS; Raevskiĭ KS
    Biull Eksp Biol Med; 1992 Jul; 114(7):47-9. PubMed ID: 1358258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neuronal responses to a non-amphetamine CNS stimulant.
    German DC; Harden H; Sanghera MK; Mann D; Kiser RS; Miller HH; Shore PA
    J Neural Transm; 1979; 44(1-2):39-49. PubMed ID: 35584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a new fluorinated tricyclic neuroleptic drug isofloxythepin on the rat striatal dopamine metabolism.
    Valchár M; Metysová J; Dlabac A
    Act Nerv Super (Praha); 1979 Oct; 21(3):130-1. PubMed ID: 42258
    [No Abstract]   [Full Text] [Related]  

  • 17. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs.
    Westerink BH; Lejeune B; Korf J; Van Praag HM
    Eur J Pharmacol; 1977 Mar; 42(2):179-90. PubMed ID: 844497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amfonelic acid and GBR 12909 on the haloperidol- and clozapine-induced activation of dopamine neurons.
    Gudelsky GA; Nwajei EE; Defife K; Nash JF
    Psychopharmacol Bull; 1992; 28(3):275-9. PubMed ID: 1480731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.